Simple noninvasive systems predict long-term outcomes of patients with nonalcoholic fatty liver disease

Gastroenterology

Volumn 145, Issue 4, 2013, Pages

  Angulo, Paul ^a   Bugianesi, Elisabetta ^b   Bjornsson, Einar S ^c   Charatcharoenwitthaya, Phunchai ^d   Mills, Peter R ^e   Barrera, Francisco ^f   Haflidadottir, Svanhildur ^c   Day, Christopher P ^g   George, Jacob ^f,h  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^b UNIVERSITY OF TURIN   (Italy)

^c LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^d MAHIDOL UNIVERSITY   (Thailand)

^e GARTNAVEL GENERAL HOSPITAL   (United Kingdom)

^f UNIVERSITY OF SYDNEY   (Australia)

^g NEWCASTLE UNIVERSITY   (United Kingdom)

^h WESTMEAD HOSPITAL   (Australia)

Author keywords

aHR, adjusted hazard ratio; ALT, alanine aminotransferase; APRI, AST platelet ratio index; AST, aspartate aminotransferase; BMI, body mass index; HCC, hepatocellular carcinoma; NAFLD, nonalcoholic fatty liver disease; NAFLD FS, NAFLD fibrosis score; NASH, nonalcoholic steatohepatitis; ROC, receiver operating characteristic

Indexed keywords

ACCURACY; ADULT; ARTICLE; BARD SCORE; COHORT ANALYSIS; FEMALE; FIB 4 SCORE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; LIVER BIOPSY; LIVER TRANSPLANTATION; LOW RISK POPULATION; MAJOR CLINICAL STUDY; MALE; NAFLD FIBROSIS SCORE; NONALCOHOLIC FATTY LIVER; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCORING SYSTEM;

EID: 84884416525     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2013.06.057     Document Type: Article

References (33)

1. D.E. Kleiner, and E.M. Brunt Nonalcoholic fatty liver disease: pathologic patterns and biopsy evaluation in clinical research Semin Liver Dis 32 2012 3 13
2. S.H. Caldwell, D.H. Oelsner, and J.C. Iezzoni Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease Hepatology 29 1999 664 666
3. F.D. Mendes, A. Suzuki, and S.O. Sanderson Prevalence and indicators of portal hypertension in patients with nonalcoholic fatty liver disease Clin Gastroenterol Hepatol 10 2012 1028 1033
4. G. Baffy, E.M. Brunt, and S.H. Caldwell Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace J Hepatol 56 2012 1384 1391
5. M.R. Charlton, J.M. Burns, and R.A. Pedersen Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States Gastroenterology 141 2011 1249 1253
6. A. Afzali, K. Berry, and G.N. Ioannou Excellent posttransplant survival for patients with nonalcoholic steatohepatitis in the United States Liver Transpl 18 2012 29 37
7. V.G. Agopian, F.M. Kaldas, and J.C. Hong Liver transplantation for nonalcoholic steatohepatitis: the new epidemic Ann Surg 256 2012 624 633
8. R. Gedaly, D.L. Davenport, and M.F. Daily Rising incidence of nonalcoholic steatoheptitis among patients transplanted for hepatocellular carcinoma in the United States Hepatology 56 Suppl 2012 40A
9. S. Bellentani, and M. Marino Epidemiology and natural history of nonalcoholic fatty liver disease (NAFLD) Ann Hepatol 8 Suppl 1 2009 S4 S8
10. S. Dam-Larsen, U. Becker, and M.B. Franzmann Final results of a long-term, clinical follow-up in fatty liver patients Scand J Gastroenterol 44 2009 1236 1243
11. M. Ekstedt, L.E. Franzen, and U.I. Mathiensen Long-term follow-up of patients with NAFLD and elevated liver enzymes Hepatology 44 2006 865 873
12. P. Angulo Long-term mortality in NAFLD: Is liver histology of any prognostic significance? Hepatology 51 2010 373 375 Erratum in: Hepatology 2010;51:1868
13. P. Angulo, J.M. Hui, and G. Marchesini The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD Hepatology 45 2007 846 854
14. C.T. Wai, J.K. Greenson, and R.J. Fontana A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C Hepatology 38 2003 518 526
15. A.G. Shah, A. Lydecker, and K. Murray Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease Clin Gastroenterol Hepatol 7 2009 1104 1112
16. S.A. Harrison, D. Oliver, and H.L. Arnold Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease Gut 57 2008 1441 1447
17. G. Musso, R. Gambino, and M. Cassader Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity Ann Med 43 2011 617 649
18. M. Demir, S. Lang, and D. Nierhoff Stepwise combination of simple noninvasive fibrosis scoring systems increases diagnosis accuracy in nonalcoholic fatty liver disease J Clin Gastroenterol 2013 Feb 24 [Epub ahead of print]
19. G.A. Grandison, and P. Angulo Can NASH be diagnoses, graded and staged nonivasively? Clin Liver Dis 16 2012 567 585
20. US Department of Health and Human Services, Public Health Service. Non-Competing Continuation Progress Report (PHS 2590). Available at: http://grants.nih.gov/grants/funding/2590/phs2590.pdf. Accessed August 13, 2013.
21. S.M. Grundy, J.I. Cleeman, S.R. Daniels American Heart Association; National Heart, Lung, and Blood Institute Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement Circulation 112 2005 2735 2752
22. D. Prati, E. Taioli, and A. Zanella Updated definitions of healthy ranges for serum alanine aminotransferase levels Ann Intern Med 137 2002 1 10
23. D.E. Kleiner, E.M. Brunt, M. Van Natta Nonalcoholic Steatohepatitis Clinical Research Network Design and validation of a histological scoring system for nonalcoholic fatty liver disease Hepatology 416 2005 1313 1321
24. E.M. Brunt, D.E. Kleiner, and L.A. Wilson Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings Hepatology 53 2011 810 820
25. R. Franchis Revising consensus in portal hypertension: Report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension J Hepatol 53 2010 762 768
26. J. Bruix, and M. Sherman Management of hepatocellular carcinoma: an update Hepatology 53 2011 1020 1022
27. D. Schuppan, and N.H. Afdhal Liver cirrhosis Lancet 371 9615 2008 838 851
28. P. Angulo, J.C. Keach, and K.P. Batts Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis Hepatology 30 1999 1356 1362
29. S.G. Sheth, S.L. Flamm, and F.D. Gordon AST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection Am J Gastroenterol 93 1998 44 48
30. C.J. Lavie, R.V. Milani, and H.O. Ventura Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss J Am Coll Cardiol 53 2009 1925 1932
31. A.G. Renehan, M. Tyson, and M. Egger Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies Lancet 371 9612 2008 569 578
32. C.K. Ryan, L.A. Johnson, and B.I. Germin One hundred consecutive hepatic biopsies in the workup of living donors for right lobe liver transplantation Liver Transpl 8 2002 1114 1122
33. C.C. Mottin, M. Moretto, and A.V. Padoin The role of ultrasound in the diagnosis of hepatic steatosis in morbidly obese patients Obes Surg 14 2004 635 637